• Kinase Inhibition in Rheumatology: Cutting Edge of the Brave New World of Therapeutics

    2 days ago - By Healio

    Yes, I started this Editorial by quoting myself - I do not think it is plagiarism as I am citing the source and I believe this is my quote. If not, then I am sorry but for all rheumatologists reading this Editorial, I don't think this concept is earth-shattering news.Think sarcoid and psoriasis from tumor necrosis factor inhibitors. Think progressive multifocal leukoencephalopathy from rituximab. Think why interleukin-17 inhibition failed rheumatoid arthritis and multiple sclerosis when all preclinical models predicted otherwise. So, the story goes with kinase inhibitors, the topic of the...
    Read more ...